Multiple myeloma (MM), lymphoma, large B-cell, diffuse (DLBCL), lymphoma
Clinical trials for Multiple myeloma (MM), lymphoma, large B-cell, diffuse (DLBCL), lymphoma explained in plain language.
Never miss a new study
Get alerted when new Multiple myeloma (MM), lymphoma, large B-cell, diffuse (DLBCL), lymphoma trials appear
Sign up with your email to follow new studies for Multiple myeloma (MM), lymphoma, large B-cell, diffuse (DLBCL), lymphoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a new immune cell therapy outsmart resistant blood cancers?
Cure Not yet recruitingThis Phase 2 trial is testing an experimental therapy called LMY-920, which uses a patient's own immune cells (T cells) engineered to recognize and attack cancer cells through a protein called BAFF. The study aims to see if this treatment can shrink tumors or eliminate signs of c…
Matched conditions: MULTIPLE MYELOMA (MM), LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL), LYMPHOMA
Phase 2 • Sponsor: Luminary Therapeutics • Aim: Cure
Last updated Aug 20, 2026 00:00 UTC
-
Why do blood cancer patients skip home care? new study aims to find out.
Knowledge-focused Not yet recruitingThis study looks at why some people with blood cancers like multiple myeloma or lymphoma choose not to receive treatment at home, or are not eligible for it. Researchers will interview patients, their caregivers, and healthcare staff, and review medical records and questionnaires…
Matched conditions: MULTIPLE MYELOMA (MM), LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL), LYMPHOMA
Sponsor: Odense University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
New study investigates brain fog after CAR-T and bispecific antibody therapies
Knowledge-focused Not yet recruitingThis study will follow 225 blood cancer patients receiving CAR-T therapy, bispecific antibodies, or high-dose chemotherapy with stem cell transplant. Researchers will test memory, attention, and thinking skills before treatment and up to 3 years after. The goal is to understand h…
Matched conditions: MULTIPLE MYELOMA (MM), LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL), LYMPHOMA
Sponsor: Aarhus University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC